Ignacio Rubio

Prof. Dr. Ignacio Rubio

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
MOMarcin F Osuchowski
Marcin F Osuchowski
MWMartin S Winkler
Martin S Winkler
TSTomasz Skirecki
Tomasz Skirecki
SCSara Cajander
Sara Cajander
MSManu Shankar-Hari
Manu Shankar-Hari
IRIgnacio Rubio
Ignacio Rubio

1 August 2015 in Biological Chemistry
Verified
Journal Article
Closed access
AHAnne Hennig
Anne Hennig
RMRobby Markwart
Robby Markwart
MEManuel A. Esparza-Franco
Manuel A. Esparza-Franco
GLGraham Ladds
Graham Ladds
IRIgnacio Rubio
Ignacio Rubio
Ras is a prototypical small G-protein and a central regulator of growth, proliferation and differentiation processes in virtually every nucleated cell. As such, Ras becomes engaged and activated by multiple growth factors, mitogens, cytokines or adhesion receptors. Ras activation comes about by changes in the steady-state equilibrium between the inactive guanosine diphosphate (GDP)-bound and active guanosine triphosphate (GTP)-bound states of Ras, resulting in the mostly transient accumulation of Ras-GTP. Three decades of intense Ras research have disclosed various families of guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs) as the two principal regulatory elements of the Ras-GDP/GTP loading status. However, with the possible exception of the GEF Sos, we still have only a rudimentary knowledge of the precise role played by many GEF and GAP members in the signalling network upstream of Ras. As for GAPs, we even lack the fundamental understanding of whether they function as genuine signal transducers in the context of growth factor-elicited Ras activation or rather act as passive modulators of the Ras-GDP/GTP cycle. Here we sift through the large body of Ras literature and review the relevant data for understanding the participation and precise role played by GEFs and GAPs in the process of Ras activation.

2 March 2024 in Cells
Verified
Journal Article
Open access
PDF file
ESElena Santacroce
Elena Santacroce
MDMiriam D'Angerio
Miriam D'Angerio
ACAlin Liviu Ciobanu
Alin Liviu Ciobanu
LMLinda Masini
Linda Masini
DTDomenico Lo Tartaro
Domenico Lo Tartaro
SBSara De Biasi
Sara De Biasi
Sepsis, a critical condition marked by systemic inflammation, profoundly impacts both innate and adaptive immunity, often resulting in lymphopenia. This immune alteration can spare regulatory T cells (Tregs) but significantly affects other lymphocyte subsets, leading to diminished effector functions, altered cytokine profiles, and metabolic changes. The complexity of sepsis stems not only from its pathophysiology but also from the heterogeneity of patient responses, posing significant challenges in developing universally effective therapies. This review emphasizes the importance of phenotyping in sepsis to enhance patient-specific diagnostic and therapeutic strategies. Phenotyping immune cells, which categorizes patients based on clinical and immunological characteristics, is pivotal for tailoring treatment approaches. Flow cytometry emerges as a crucial tool in this endeavor, offering rapid, low cost and detailed analysis of immune cell populations and their functional states. Indeed, this technology facilitates the understanding of immune dysfunctions in sepsis and contributes to the identification of novel biomarkers. Our review underscores the potential of integrating flow cytometry with omics data, machine learning and clinical observations to refine sepsis management, highlighting the shift towards personalized medicine in critical care. This approach could lead to more precise interventions, improving outcomes in this heterogeneously affected patient population.

16 November 2023 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
PKPuja Kumari
Puja Kumari
SVSwathy O. Vasudevan
Swathy O. Vasudevan
ARAshley J. Russo
Ashley J. Russo
SWSkylar S. Wright
Skylar S. Wright
Víctor Fraile-ÁgredaVíctor Fraile-Ágreda
Víctor Fraile-Ágreda
VRVijay A. Rathinam
Vijay A. Rathinam

1 January 2014 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
MAMartin Augsten
Martin Augsten
ABAnika Böttcher
Anika Böttcher
RSRainer Spanbroek
Rainer Spanbroek
IRIgnacio Rubio
Ignacio Rubio
KFKarlheinz Friedrich
Karlheinz Friedrich
Ras is a membrane-associated small G-protein that funnels growth and differentiation signals into downstream signal transduction pathways by cycling between an inactive, GDP-bound and an active, GTP-bound state. Aberrant Ras activity as a result of oncogenic mutations causes de novo cell transformation and promotes tumor growth and progression.

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JJJesse E. Jun
Jesse E. Jun
IRIgnacio Rubio
Ignacio Rubio
Jeroen RooseJeroen Roose
Jeroen Roose
The Ras-MAPK signaling pathway is highly conserved throughout evolution and is activated downstream of a wide range of receptor stimuli. Ras guanine nucleotide exchange factors (RasGEFs) catalyze GTP loading of Ras and play a pivotal role in regulating receptor-ligand induced Ras activity. In T cells, three families of functionally important RasGEFs are expressed: RasGRF, RasGRP, and SOS-family GEFs. Early on it was recognized that Ras activation is critical for T cell development and that the RasGEFs play an important role herein. More recent work has revealed that nuances in Ras activation appear to significantly impact T cell development and selection. These nuances include distinct biochemical patterns of analog versus digital Ras activation, differences in cellular localization of Ras activation, and intricate interplays between the RasGEFs during distinct T cell developmental stages as revealed by various new mouse models. In many instances, the exact nature of these nuances in Ras activation or how these may result from fine-tuning of the RasGEFs is not understood. One large group of biomolecules critically involved in the control of Ras-GEFs´functions are lipid second messengers. Multiple, yet distinct lipid products are generated following T cell receptor (TCR) stimulation and bind to different domains in the RasGRP and SOS RasGEFs to facilitate the activation of the membrane-anchored Ras GTPases. In this review we highlight how different lipid-based elements are generated by various enzymes downstream of the TCR and other receptors and how these dynamic and interrelated lipid products may fine-tune Ras activation by RasGEFs in developing T cells.